ESMO 2025: Darolutamide-Treated mHSPC Patients Show a More Durable and Stronger PSA Response vs Abiraterone
/ Alicia Morgans / Jan Andreasen
ESMO 2025: The Future of Oncology Will Be Built by Individuals
/ Jan Andreasen
Hvis du er lege, sykepleier eller annet helsepersonell kan du:
Hvis du allerede har en profil:
Logg in